SeaStar Medical Holding Corporation (NASDAQ: ICU) — Healthcare · Share Price, Chart & Market Data
About: SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.13 (-2.59%)
ICUSeaStar Medical Holding Corporation
Loading watchlist status…
Trade ICU now
SeaStar Medical Holding Corporation share price
ICU price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:00 pm GMT+0
ICU price performance
-3.73%
5D
50.73%
1M
1,470.342%
YTD
225.197%
1Y
ICU price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:00 pm GMT+0
ICU Market Signals